Clinical Trials
4 trialsNCT06788509 2026-06-05
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
NCT00923442 2026-06-04
Biology Studies of Hematologic Cancers
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT01728402 2026-02-17
Pathogenesis of Hematologic Malignancies
OHSU Knight Cancer Institute
Enrolling by invitation
NCT04093570 2025-10-31
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Taiho Oncology, Inc.
Phase 2 Enrolling by invitation